// App-Quantinova.ai

: A Risk Assessment Model for the Identification of Sickle Cell Disease Patients at Risk for Venous Thromboembolism

Researchers

Presenter

  • Jifang Zhou

Principal Investigators

  • Gregory Sampang Calip

  • Edith A. Nutescu

Medical Centers

  • University of Illinois at Chicago College of Pharmacy, Chicago, IL

  • Department of Pharmacy Systems, Outcomes and Policy, University of Illinois at Chicago, Chicago, IL

  • Center for Pharmacoepidemiology and Pharmacoeconomic Research, University of Illinois at Chicago, Chicago, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

  • Sickle cell anemia

Biomarkers

  • Stearoyl-CoA desaturase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved